A significant scientific advancement has been made in Bangladesh regarding regulatory T cells (Treg), according to a report by bdnews24.com. These specialized white blood cells act as the immune system's brakes, preventing excessive immune responses that could damage the body's own tissues. Researchers say understanding Treg cell function could lead to breakthroughs in treating autoimmune diseases, allergies, and cancer.
Core Research Findings
Regulatory T cells function as the immune system's control mechanism. When pathogens enter the body, the immune system activates to fight the infection.
However, if this activation becomes excessive, it can attack the body's own cells. Treg cells regulate this overactivity, protecting the body from self-inflicted damage.
The research revealed that when Treg cell numbers or function decline, the risk of autoimmune diseases such as rheumatoid arthritis, type-1 diabetes, and multiple sclerosis increases significantly. Conversely, in cancer patients, overactive Treg cells help tumors evade the body's immune response.
Expert Perspectives
Specialists involved in the research stated that controlling these cells' behavior could yield benefits in two directions. First, enhancing Treg cell function in autoimmune disease patients could improve their condition. Second, reducing Treg cell activity in cancer treatment would enable the body's own immune system to attack tumors effectively.
Future Plans
Researchers have announced they are preparing for clinical trials based on these findings. Initial laboratory results have been successful, but further extensive testing is required before human application. This research has earned international scientific recognition and is considered a significant step forward for Bangladesh's medical and biological research capabilities.